Eisai
4523.T
#2098
Rank
HK$70.82 B
Marketcap
HK$251.26
Share price
-0.39%
Change (1 day)
30.10%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): HK$6.78

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$6.79. an increase over its 2024 EPS that were of HK$7.65.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025HK$8.5611.85%
2024HK$7.65-32.63%
2023HK$11.365.52%
2022HK$10.76-74.01%
2021HK$41.41-66.58%
2020HK$123.9098.24%
2019HK$62.5017.01%
2018HK$53.4137.78%
2017HK$38.77-27.62%
2016HK$53.5635.33%
2015HK$39.58-2.82%
2014HK$40.73-27.66%
2013HK$56.31-27.49%
2012HK$77.66-12.67%
2011HK$88.9388.08%
2010HK$47.28-11.06%
2009HK$53.16-390.15%
2008-HK$18.32-127.78%
2007HK$65.9611.78%
2006HK$59.014.38%
2005HK$56.547.4%
2004HK$52.6543.03%
2003HK$36.8125.09%
2002HK$29.4352.67%
2001HK$19.2769.76%
2000HK$11.35